Document is current

Article History

Received: 25 July 2025

Accepted: 14 August 2025

First Online: 9 September 2025

Declarations

:

: No human or animal experiments were performed in preparation of the current manuscript. All reported studies with human subjects discussed in the current manuscript have been published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and institutional guidelines).

: Dr. Colantonio received support research from Amgen. Dr. Bittner received research grants to her institution from Sanofi and Regeneron (ODYSSEY OUTCOMES trial, Steering Committee member), Esperion (CLEAR OUTCOMES trial, National Coordinator), Dalcor (DalGene trial, National Coordinator), Novartis (ORION trial, Site PI), Amgen (EVOLVE MI), NIH / Subcontract from Wake Forest (RehabHFpEF). Dr. Bitter also receives payments as a Data Safety Monitoring Board member (Eli Lilly, ongoing; Verve Therapeutics, ongoing) and received consulting fees from New Amsterdam.